Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family
Guida Landouré(Université des Sciences, des Techniques et des Technologies de Bamako), Charlotte J. Sumner(Johns Hopkins University), Oumarou Diallo(National Institutes of Health), Bryan J. Traynor(National Institutes of Health), Clare H. Munns(Institute of Ophthalmology), J. Raphael Gibbs(National Institutes of Health), Kenneth H. Fischbeck(National Institute of Neurological Disorders and Stroke), Rachelle Gaudet(Harvard University), Christy L. Ludlow(Northwood University), Janel O. Johnson(National Institutes of Health), Yijun Shi(National Institutes of Health), Jeremy M. Sullivan(Johns Hopkins University), Barrington G. Burnett(Uniformed Services University of the Health Sciences)
Cited by 41
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy
|The American Journal of Human Genetics|2016|449
Myasthenia Gravis
|New England Journal of Medicine|1977|435
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
|Journal of Neurology Neurosurgery & Psychiatry|2014|342
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
|Annals of Neurology|2003|288